Drug
Vestipitant clinical trials
Also written GW597599.
Includes 1 study of Vestipitant mesylate.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2002
How studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
8 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 0
GlaxoSmithKline (6) · Accenture (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses vestipitant is read from its arms, and is right about nine times in ten.
Testing it · 8
- A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive DisorderCompletedPhase 2GlaxoSmithKlineNCT00048204Written as GW597599B
- A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary InsomniaCompletedPhase 2GlaxoSmithKlineNCT00606697Written as GW597599
- Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female PatientsCompletedPhase 2GlaxoSmithKlineNCT00600990Written as GW597599
- Vestipitant 28-day Tolerance StudyCompletedPhase 2GlaxoSmithKlineNCT00992160Written as GW597599
- Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.CompletedPhase 2GlaxoSmithKlineNCT00394056Written as Vestipitant
- A Combination Therapy In Patients With Social Anxiety DisorderCompletedPhase 2GlaxoSmithKlineNCT00403962Written as vestipitant/paroxetine
- A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)CompletedPhase 2AccentureNCT01507194Written as Vestipitant
- Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)CompletedPhase 1AccentureNCT01290133Written as GW597599
Codes
What other systems call vestipitant · ClinicalTrials.gg INT005380
- MeSH (NLM) C534550vestipitantConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S052TOI9BIVESTIPITANTConfirmed FDA, NLM, Wikidata
- Wikidata Q12747348vestipitantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C95194VestipitantOne source FDA
- DrugBank DB11949One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C534550 | vestipitant | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S052TOI9BI | VESTIPITANT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q12747348 | vestipitant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C95194 | Vestipitant | One source FDA |
| DrugBank | DB11949 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.